Cargando…
The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency
Adeno-associated virus (AAV) vector is a critical tool for gene delivery through its durable transgene expression and safety profile. Among many serotypes, AAV2-retro is typically utilized for dissecting neural circuits with its retrograde functionality. However, this vector requires a relatively lo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358834/ https://www.ncbi.nlm.nih.gov/pubmed/35941689 http://dx.doi.org/10.1186/s13041-022-00957-0 |
_version_ | 1784764013845938176 |
---|---|
author | Nakahama, Ryota Saito, Aika Nobe, Sensho Togashi, Kazuya Suzuki, Ikuo K. Uematsu, Akira Emoto, Kazuo |
author_facet | Nakahama, Ryota Saito, Aika Nobe, Sensho Togashi, Kazuya Suzuki, Ikuo K. Uematsu, Akira Emoto, Kazuo |
author_sort | Nakahama, Ryota |
collection | PubMed |
description | Adeno-associated virus (AAV) vector is a critical tool for gene delivery through its durable transgene expression and safety profile. Among many serotypes, AAV2-retro is typically utilized for dissecting neural circuits with its retrograde functionality. However, this vector requires a relatively long-term incubation period (over 2 weeks) to obtain enough gene expression levels presumably due to low efficiency in gene transduction. Here, we aimed to enhance transgene expression efficiency of AAV2-retro vectors by substituting multiple tyrosine residues with phenylalanines (YF mutations) in the virus capsid, which is previously reported to improve the transduction efficiency of AAV2-infected cells by evading host cell responses. We found that AAV2-retro with YF mutations (AAV2-retroYF)-mediated transgene expression was significantly enhanced in the primary culture of murine cortical neurons at 1 week after application, comparable to that of the conventional AAV2-retro at 2 week after application. Moreover, transgene expressions in the retrogradely labeled neurons mediated by AAV2-retroYF were significantly increased both in the cortico-cortical circuits and in the subcortical circuits in vivo, while the retrograde functionality of AAV2-retroYF was equally effective as that of AAV2-retro. Our data indicate that YF mutations boost AAV2-retro-mediated retrograde gene transduction in vivo and suggest that the AAV2-retroYF should be useful for efficient targeting of the projection-defined neurons, which is suited to applications for dissecting neural circuits during development as well as future clinical applications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00957-0. |
format | Online Article Text |
id | pubmed-9358834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93588342022-08-10 The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency Nakahama, Ryota Saito, Aika Nobe, Sensho Togashi, Kazuya Suzuki, Ikuo K. Uematsu, Akira Emoto, Kazuo Mol Brain Research Adeno-associated virus (AAV) vector is a critical tool for gene delivery through its durable transgene expression and safety profile. Among many serotypes, AAV2-retro is typically utilized for dissecting neural circuits with its retrograde functionality. However, this vector requires a relatively long-term incubation period (over 2 weeks) to obtain enough gene expression levels presumably due to low efficiency in gene transduction. Here, we aimed to enhance transgene expression efficiency of AAV2-retro vectors by substituting multiple tyrosine residues with phenylalanines (YF mutations) in the virus capsid, which is previously reported to improve the transduction efficiency of AAV2-infected cells by evading host cell responses. We found that AAV2-retro with YF mutations (AAV2-retroYF)-mediated transgene expression was significantly enhanced in the primary culture of murine cortical neurons at 1 week after application, comparable to that of the conventional AAV2-retro at 2 week after application. Moreover, transgene expressions in the retrogradely labeled neurons mediated by AAV2-retroYF were significantly increased both in the cortico-cortical circuits and in the subcortical circuits in vivo, while the retrograde functionality of AAV2-retroYF was equally effective as that of AAV2-retro. Our data indicate that YF mutations boost AAV2-retro-mediated retrograde gene transduction in vivo and suggest that the AAV2-retroYF should be useful for efficient targeting of the projection-defined neurons, which is suited to applications for dissecting neural circuits during development as well as future clinical applications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-022-00957-0. BioMed Central 2022-08-08 /pmc/articles/PMC9358834/ /pubmed/35941689 http://dx.doi.org/10.1186/s13041-022-00957-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nakahama, Ryota Saito, Aika Nobe, Sensho Togashi, Kazuya Suzuki, Ikuo K. Uematsu, Akira Emoto, Kazuo The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title | The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title_full | The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title_fullStr | The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title_full_unstemmed | The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title_short | The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
title_sort | tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358834/ https://www.ncbi.nlm.nih.gov/pubmed/35941689 http://dx.doi.org/10.1186/s13041-022-00957-0 |
work_keys_str_mv | AT nakahamaryota thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT saitoaika thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT nobesensho thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT togashikazuya thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT suzukiikuok thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT uematsuakira thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT emotokazuo thetyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT nakahamaryota tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT saitoaika tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT nobesensho tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT togashikazuya tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT suzukiikuok tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT uematsuakira tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency AT emotokazuo tyrosinecapsidmutationsonretrogradeadenoassociatedvirusacceleratesgenetransductionefficiency |